This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.
Agricola
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, August 2005, p. 4938-4940, Vol. 71, No. 8
0099-2240/05/$08.00+0     doi:10.1128/AEM.71.8.4938-4940.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

SHORT REPORT

Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum

Daniel D. Mosel, Raluca Dumitru, Jacob M. Hornby,{dagger} Audrey L. Atkin, and Kenneth W. Nickerson*

School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666

Received 5 February 2005/ Accepted 11 March 2005


arrow
ABSTRACT
 
Concentrations of (E,E)-farnesol needed to inhibit germ tube formation were determined for Candida albicans strains A72 and SC5314 by using six different conditions known to trigger germination. For defined media, 1 to 2 µM farnesol was sufficient. However, with serum at 2 to 20%, up to 250 µM farnesol was required. Farnesol blocked germ tube formation but did not block elongation of existing germ tubes.


arrow
INTRODUCTION
 
Fungal yeast-mycelium dimorphism is of interest because of the economic and medical importance of dimorphic fungi and because these organisms may serve as model systems for studying differentiation. Farnesol is a fungal quorum-sensing molecule with intriguing regulatory properties in Candida albicans (7). This compound is excreted continuously by C. albicans (7), and when it accumulates beyond a threshold level, it blocks the yeast-to-mycelium conversion (7). Farnesol blocks mycelial development initiated by any of three chemically distinct triggers for germ tube formation: L-proline, N-acetylglucosamine, and serum (7). Of these, serum (10 to 20% [vol/vol] at 37°C) has been used most commonly (9, 15). Serum has even been described as the "magic potion" for the induction of germ tubes by C. albicans (5). Thus, both farnesol's mode of action and the therapeutic potential of farnesol analogs are of interest.

By stationary phase, 2 to 4 µM farnesol, which is at a concentration well above the 1.2 µM concentration needed to block germ tube formation in an N-acetylglucosamine-stimulated differentiation assay (17), has accumulated in cultures of C. albicans (7, 8). However, some recent studies (10, 11, 16, 18, 19) with farnesol and C. albicans have used farnesol concentrations (250 to 500 µM) that we believe are much higher than those that are physiologically relevant. Farnesol is a lipophilic molecule that can accumulate in membranes, and the farnesol effects observed at these concentrations may be nonspecific. In some cases, these higher concentrations may result in physiological artifacts. Indeed, Kim et al. (10) found that 450 µM farnesol inhibited growth of C. albicans by 35%.

Our objectives in this study were threefold: (i) to identify the minimum levels of farnesol needed to block germ tube formation in six media commonly used to trigger germination; (ii) to establish the physiological relevance of the production levels we have observed, 2 to 4 µM farnesol (7, 8); and (iii) to test our hypothesis that much higher levels of farnesol are needed to block germ tube formation in serum. This hypothesis was developed because of the presence of albumins in serum; albumins are noted for their nonspecific lipid binding capacity (20).

Procedures for the growth and storage of C. albicans were as described previously (7, 8, 17). Strain A72 is also ATCC MYA-2430. Strain SC5314 was used for the genomic sequence for C. albicans (www.candidagenome.org). (E,E)-Farnesol (Sigma Chemical, St. Louis, MO) was freshly prepared as a stock solution (10 mM) in methanol and stored under nitrogen to prevent oxidation (17).

All resting cell preparations were washed three times in 50 mM potassium phosphate buffer (pH 6.5) prior to use. Resting cells were inoculated into 5 ml of prewarmed (37°C) medium at a cell density of 2 x 107 per ml and incubated in 25-ml flasks at 37°C with aeration by shaking at 200 rpm on a G2 shaker (New Brunswick Scientific Co., Edison, NJ). Samples were removed periodically for microscopic examination.

The liquid media used were (i) 2.5 mM N-acetylglucosamine with imidazole and magnesium (7), (ii) glucose phosphate proline (GPP) (7, 12), (iii) Lee's medium (13), (iv) yeast nitrogen base without amino acids but supplemented with 2.5 mM N-acetylglucosamine (1), (v) RPMI 1640 (1) (Invitrogen), and (vi) serum (2 to 20%) in distilled, deionized water. Pig, horse, sheep, and bovine sera were obtained from the Meat Animal Research Center, Clay Center, Nebr. The solid medium used was GPP with 1.5% agar. After being autoclaved, the molten medium was cooled to 45°C and then added to 100- by 15-mm plastic petri dishes (20 ml medium/dish) containing appropriate aliquots of farnesol. The dishes were swirled to mix the farnesol into the medium before the agar solidified. Because the 20 ml per petri dish was estimated by eye, the resulting farnesol concentrations also differ somewhat. We believe the medium volumes are accurate to ±1 ml, and thus, the farnesol concentrations would be accurate to ±5%. Germ tube formation was quantified on plates by using a Labophot-2 microscope (Nikon Inc. Instrument Group, Melville, NY) modified as a tetrad dissection microscope (Micro Video Instruments, Avon, MA) using a Plan 10/0.30 objective lens.


arrow
Farnesol concentrations with and without serum.
 
Control cultures with no farnesol always had 98 to 100% germ tubes. For each of the defined media, the level of farnesol needed to reduce germ tube formation to 50% was ~1 µM for both strains of C. albicans (Table 1). Also, the levels of farnesol needed were the same for liquid and solid GPP media (Table 1); they were not influenced by the presence of agar. However, the farnesol levels needed were influenced dramatically by the presence of serum. Serum increased the amount of farnesol needed in a dose-dependent manner (Table 1), which reached 150 to 250 µM farnesol at 10 to 20% serum. Virtually identical results were obtained with pig serum, horse serum, sheep serum, and bovine serum (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Concentration of farnesol needed to reduce germ tube formation to 50%


arrow
Commitment.
 
We also sought to clarify the effect of farnesol on preexisting hyphae (Fig. 1). Germ tube formation was blocked completely when farnesol was added at any time up to 30 min after inoculation. However, it was not blocked at all when the farnesol was added 90 min after inoculation, and it was stopped at an intermediate value (ca. 60% germ tubes) when the farnesol was added 60 min after inoculation (Fig. 1). These experiments were done with both strain A72 and strain SC5314 in both the N-acetylglucosamine differentiation medium and the GPP growth medium. The data shown in Fig. 1 are for SC5314 in GPP. In all cases, farnesol blocked germ tube formation by cells that did not already have visible germ tubes. These cells formed buds instead. However, farnesol neither reversed nor altered germ tube formation by cells that already had visible germ tubes. Those cells were committed to mycelial development (2, 14). Thus, farnesol does not halt the growth or elongation of existing mycelia, even at concentrations as high as 50 µM. When farnesol was added 2 hours after the inoculation of C. albicans A72 in N-acetylglucosamine, the germ tubes continued to elongate for at least the next 3.5 hours (6). Ramage et al. (16) reported a similar phenomenon during biofilm formation by C. albicans. Once hyphal formation had been initiated, it was not inhibited by the addition of farnesol (16). The present work extends their finding to include other, nonbiofilm germ tube-forming conditions.



View larger version (11K):
[in this window]
[in a new window]
 
FIG. 1. Kinetics of germ tube formation (GTF) with farnesol added at various time points. C. albicans SC5314 was grown in GPP medium at 37°C, and farnesol (30 µM) was added at time zero ({blacksquare}), 30 min (•), 60 min ({blacktriangleup}), and 90 min ({blacklozenge}). X, no farnesol addition. Values shown are the averages of duplicate measurements conducted on separate days which agreed within ±5%. The values for the samples with farnesol added at 90 min were the same as those with no farnesol addition.

The disparity in farnesol concentrations needed with and without serum (Table 1) is consistent with our hypothesis on the farnesol binding capacity of serum albumins. Albumins play an important role in the transport of sparingly soluble metabolic products from one tissue to another (20). Substances such as dyes, fatty acids, bilirubin, sulfonamides, and naphthoquinone derivatives, all of which are sparingly soluble in water, are readily dissolved in albumin solutions (20), and in each instance, it has been demonstrated that the dissolved substance is actually bound to the protein (20). Farnesol is also sparingly soluble in water (7). These differences with and without serum further illustrate the advantages of working with chemically defined media. Moreover, the fatty acid binding abilities of serum albumins can be exploited; adding fatty acid-deficient bovine serum albumin (0.4%) is a common mechanism for avoiding the toxic effects of excess fatty acids. The added albumins create a slow-release fatty acid buffer (3). We expect that the influences of farnesol on cell morphology will differ greatly during pathogenesis depending on location within the body. Two relevant factors would be the presence of albumins and the degree of anaerobicity, since C. albicans does not excrete farnesol under strictly anaerobic conditions (4).


arrow
ACKNOWLEDGMENTS
 
This work was supported by grants from the National Science Foundation (MCB-0110999) and the University of Nebraska Tobacco Settlement Biomedical Research Enhancement Fund. D. D. Mosel, an undergraduate student at Nebraska Wesleyan University, Lincoln, was supported by a grant from the Howard Hughes Medical Institute to Nebraska Wesleyan University.

We thank Susan Hassler and Joe Ford, Meat Animal Research Center, Clay Center, Nebr., for providing the serum samples.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: School of Biological Sciences, University of Nebraska, Lincoln, NE 68588-0666. Phone: (402) 472-2253. Fax: (402) 472-8722. E-mail: knickerson1{at}unl.edu. Back

{dagger} Present address: Division of Natural Sciences, Lewis-Clark State College, Lewiston, ID 83501. Back


arrow
REFERENCES
 
    1
  1. Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Boca Raton, Fla.
  2. 2
  3. Chaffin, W. L., and D. E. Wheeler. 1981. Morphological commitment in Candida albicans. Can. J. Microbiol. 27:131-137.[Medline]
  4. 3
  5. Das, D. V. M., and G. Weeks. 1979. Effects of polyunsaturated fatty acids on the growth and differentiation of the cellular slime mould, Dictyostelium discoideum. Exp. Cell Res. 118:237-243.[Medline]
  6. 4
  7. Dumitru, R., J. M. Hornby, and K. W. Nickerson. 2004. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob. Agents Chemother. 48:2350-2354.[Abstract/Free Full Text]
  8. 5
  9. Ernst, J. F. 2000. Transcription factors in Candida albicans—environmental control of morphogenesis. Microbiology 146:1763-1774.[Free Full Text]
  10. 6
  11. Hornby, J. M. 2003. Quorum sensing and the regulation of morphology in the dimorphic fungus Candida albicans. Ph.D. thesis. University of Nebraska—Lincoln, Lincoln.
  12. 7
  13. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.[Abstract/Free Full Text]
  14. 8
  15. Hornby, J. M., and K. W. Nickerson. 2004. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother. 48:2305-2307.[Abstract/Free Full Text]
  16. 9
  17. Hudson, D. A., Q. L. Sciascia, R. J. Sanders, G. E. Norris, P. J. B. Edwards, P. A. Sullivan, and P. C. Farley. 2004. Identification of the dialyzable serum inducer of germ-tube formation in Candida albicans. Microbiology 150:3041-3049.[Abstract/Free Full Text]
  18. 10
  19. Kim, S., E. Kim, D.-S. Shin, H. Kang, and K.-B. Oh. 2002. Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism. Bioorg. Med. Chem. Lett. 12:895-898.[CrossRef][Medline]
  20. 11
  21. Kruppa, M., B. P. Krom, N. Chauchan, A. V. Bambach, R. L. Cihlar, and R. A. Calderone. 2004. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot. Cell 3:1062-1065.[Abstract/Free Full Text]
  22. 12
  23. Kulkarni, R. K., and K. W. Nickerson. 1981. Nutritional control of dimorphism in Ceratocystis ulmi. Exp. Mycol. 5:148-154.
  24. 13
  25. Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.[Medline]
  26. 14
  27. Mitchell, L. H., and D. R. Soll. 1979. Commitment to germ tube or bud formation during release from stationary phase in Candida albicans. Exp. Cell Res. 120:167-179.[CrossRef][Medline]
  28. 15
  29. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
  30. 16
  31. Ramage, G., S. P. Saville. B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.[Abstract/Free Full Text]
  32. 17
  33. Schepin, R., J. M. Hornby, E. Burger, T. Niessen, P. Dussault, and K. W. Nickerson. 2003. Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem. Biol. 10:743-750.[CrossRef][Medline]
  34. 18
  35. Soto, T., T. Watanabe, T. Mikami, and T. Matsumoto. 2004. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol. Pharm. Bull. 27:751-752.[CrossRef][Medline]
  36. 19
  37. Uppuluri, P., and L. Chaffin. 2004. Effect of farnesol on expression of Candida albicans stationary phase genes SNO1 and SNZ1. Abstr. 7th Am. Soc. Microbiol. Candida Candidiasis Conf., Austin, Tex., abstr. 243.
  38. 20
  39. White, A., P. Handler, and E. L. Smith. 1959. Principles of biochemistry, 3rd ed. McGraw-Hill, New York, N.Y.


Applied and Environmental Microbiology, August 2005, p. 4938-4940, Vol. 71, No. 8
0099-2240/05/$08.00+0     doi:10.1128/AEM.71.8.4938-4940.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kebaara, B. W., Langford, M. L., Navarathna, D. H. M. L. P., Dumitru, R., Nickerson, K. W., Atkin, A. L. (2008). Candida albicans Tup1 Is Involved in Farnesol-Mediated Inhibition of Filamentous-Growth Induction. Eukaryot Cell 7: 980-987 [Abstract] [Full Text]  
  • Martins, M., Henriques, M., Azeredo, J., Rocha, S. M., Coimbra, M. A., Oliveira, R. (2007). Morphogenesis Control in Candida albicans and Candida dubliniensis through Signaling Molecules Produced by Planktonic and Biofilm Cells. Eukaryot Cell 6: 2429-2436 [Abstract] [Full Text]  
  • Navarathna, D. H. M. L. P., Nickerson, K. W., Duhamel, G. E., Jerrels, T. R., Petro, T. M. (2007). Exogenous Farnesol Interferes with the Normal Progression of Cytokine Expression during Candidiasis in a Mouse Model. Infect. Immun. 75: 4006-4011 [Abstract] [Full Text]  
  • Rossignol, T., Logue, M. E., Reynolds, K., Grenon, M., Lowndes, N. F., Butler, G. (2007). Transcriptional Response of Candida parapsilosis following Exposure to Farnesol. Antimicrob. Agents Chemother. 51: 2304-2312 [Abstract] [Full Text]  
  • Alem, M. A. S., Oteef, M. D. Y., Flowers, T. H., Douglas, L. J. (2006). Production of Tyrosol by Candida albicans Biofilms and Its Role in Quorum Sensing and Biofilm Development. Eukaryot Cell 5: 1770-1779 [Abstract] [Full Text]  
  • Nickerson, K. W., Atkin, A. L., Hornby, J. M. (2006). Quorum sensing in dimorphic fungi: farnesol and beyond.. Appl. Environ. Microbiol. 72: 3805-3813 [Full Text]  
  • Hogan, D. A. (2006). Talking to themselves: autoregulation and quorum sensing in fungi.. Eukaryot Cell 5: 613-619 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.
Agricola
Right arrow Articles by Mosel, D. D.
Right arrow Articles by Nickerson, K. W.